• ქართული
  • English
  • Allergan says revenue from aesthetics unit may double by 2025

    Allergan Plc said revenue from its medical aesthetics business could double by 2025, even as it faces increasing competition for its blockbuster wrinkle treatment, Botox.

    Market Quotes by TradingView